Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 18 Jan 2024 for Recursion Pharmaceuticals, INC., €37k. Read the official filing
Filing timeline
BuySaleShafique Virani
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Shafique Virani: trading record in brief
Shafique Virani, listed as senior executive, appears in our data through filings on Recursion Pharmaceuticals, Inc. shares, published by SEC (Form 4). Between 2 June 2021 and 16 January 2024, the trades on record add up to 22 filings.
No open-market purchase appears, only 1 sale worth €199k. The rest of the record consists of 7 share grants and 14 option exercises.
On 18 January 2024 came the latest disclosure, an option exercise for €37k in Recursion Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Shafique Virani
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
18,000 shares@ US$2.224.4% of flowClass A Common StockSEC:0001209191-24-001870:0
18,000 shares@ US$2.224.4% of flowClass A Common StockSEC:0001209191-23-059254:0
18,000 shares@ US$2.224.4% of flowClass A Common StockSEC:0001209191-23-055843:0
18,000 shares@ US$2.224.6% of flowClass A Common StockSEC:0001209191-23-053107:0
18,000 shares@ US$2.225.0% of flowClass A Common StockSEC:0001209191-23-050033:0
3,603 shares@ US$9.193.7% of flowClass A Common StockSEC:0001209191-23-046424:0
20,000 shares@ US$2.224.8% of flowClass A Common StockSEC:0001209191-23-043581:0
30,000 shares@ US$2.227.2% of flowClass A Common StockSEC:0001209191-23-042794:0
30,000 shares@ US$2.227.3% of flowClass A Common StockSEC:0001209191-23-038616:0
25,000 shares@ US$8.5824.1% of flowClass A Common StockSEC:0001209191-23-034601:0
2,230 shares@ US$5.601.4% of flowClass A Common StockSEC:0001209191-23-030380:0
7,486 shares@ US$2.221.9% of flowClass A Common StockSEC:0001209191-23-010774:0
106,253 shares0Class A Common StockSEC:0001209191-23-007045:0
5,000 shares@ US$2.221.2% of flowClass A Common StockSEC:0001209191-23-004043:0
5,000 shares@ US$2.221.3% of flowClass A Common StockSEC:0001209191-22-061999:0
613 shares@ US$11.860.9% of flowClass A Common StockSEC:0001209191-22-057708:0
5,000 shares@ US$2.221.4% of flowClass A Common StockSEC:0001209191-22-053981:0
5,000 shares@ US$2.221.3% of flowClass A Common StockSEC:0001209191-22-050400:0
613 shares@ US$12.960.9% of flowClass A Common StockSEC:0001209191-22-046464:0
870 shares@ US$5.670.0002% mcap2.8% of flowClass A Common StockSEC:0001209191-22-030257:0
40,225 shares0Class A Common StockSEC:0001209191-22-007918:0
45,045 shares@ US$2.2211.0% of flowClass A Common StockSEC:0001209191-21-038174:0
22 of 22 declarations
